Exelixis director receives 8,367-share RSU grant

Heyman Tomas J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Heyman Tomas J. reported acquisition or exercise transactions in this Form 4 filing.

Exelixis director Tomas J. Heyman received a new equity award. He was granted 8,367 restricted stock units (RSUs) of Exelixis common stock on May 27, 2026 under the 2017 Equity Incentive Plan, with no cash paid per share.

Each RSU equals one share of common stock and will vest 100% on May 27, 2027, if he continues serving through that date. After this grant, Heyman holds 50,649 shares in total, including 17,455 shares that will be issued when previously granted RSUs vest.

Insider Trade Summary

Grant/Award: 8,367 shares

Grant/Award 1 txn

Insider Heyman Tomas J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,367	$0.00	$0.00

Holdings After Transaction: Common Stock — 50,649 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.
2. F2. Includes 17,455 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Key Figures

RSU grant size: 8,367 RSUs Transaction price per share: $0.0000 per share Total holdings after transaction: 50,649 shares +1 more

4 metrics

RSU grant size 8,367 RSUs Granted on May 27, 2026 to director Tomas J. Heyman

Transaction price per share $0.0000 per share Equity compensation grant, no cash paid

Total holdings after transaction 50,649 shares Common stock beneficially owned after RSU grant

Unvested RSU-related shares 17,455 shares Shares to be issued upon vesting of existing RSUs

Key Terms

restricted stock units ("RSUs"), 2017 Equity Incentive Plan, economic equivalent, continuous service

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2017 Equity Incentive Plan financial

"granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan"

economic equivalent financial

"Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock"

continuous service financial

"The RSUs will vest as to 100% of the shares ... subject to the Reporting Person's continuous service through that date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Exelixis (EXEL) director Tomas J. Heyman report in this Form 4?

Tomas J. Heyman reported receiving 8,367 restricted stock units (RSUs) of Exelixis common stock as a compensation grant. The award was made under the 2017 Equity Incentive Plan and involves no cash purchase price per share.

How many Exelixis (EXEL) RSUs did Tomas J. Heyman receive and when do they vest?

He received 8,367 RSUs that each represent one Exelixis common share. The RSUs will vest 100% on May 27, 2027, conditional on his continuous service with the company through that vesting date.

What are Tomas J. Heyman’s total Exelixis (EXEL) holdings after this RSU grant?

After the grant, Heyman holds 50,649 Exelixis shares in total. This figure includes 17,455 shares that will be issued to him in the future when previously awarded RSUs vest according to their terms.

Was cash paid for the Exelixis (EXEL) RSU grant to Tomas J. Heyman?

No cash was paid for this RSU grant; the transaction price per share is reported as 0.0000. The award is part of his equity compensation, issued under the Exelixis, Inc. 2017 Equity Incentive Plan.

Is this Exelixis (EXEL) Form 4 an open-market stock purchase or sale?

This filing shows a grant of 8,367 RSUs, not an open-market trade. The transaction code is "A" for a grant or award acquisition, representing equity compensation rather than a market buy or sell transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 05:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heyman Tomas J.

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		A		8,367(1)	A	$0	50,649(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.

2. Includes 17,455 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)